Pro-LT
Pro-LT, licence 80045694: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Bel Marra Nutritionals Inc.
- NPN or DIN-HM
- 80045694
- Status
- Active licence
- Licence date
- 23 October 2013
- Revision date
- 28 November 2021
- Form
- Capsule
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Vitamine B12 | 3.0 mcg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 600.0 mcg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 800.0 mcg | Not calculated |
| Bacopa monnieri Source : Feuille Potency : 50.0 % Total bacosides | 150.0 mg | Not calculated |
| Withania somnifera Source : Racine Potency : 1.5 % Withanolides | 300.0 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 10.0 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - racine Extraction ratio : 3:1 Dry plant equivalent : 300 mg Potency : 4.0 % Total ginsenosides | 100.0 mg | Not calculated |
| Riboflavine Source : Riboflavine | 600.0 mcg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive function and reduce mental fatigue (in cases of mental stress). Helps to temporarily promote relaxation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80045694
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.